Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.

CONCLUSIONS: Eribulin treatment line was identified as indepedent prognostic factor for PFS in MBC patients. PMID: 31786850 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research

Related Links:

ConclusionThe scale appears to be a reliable and valid tool to measure chemotherapy-induced alopecia distress among breast cancer patients in China.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
Hair loss is one of the most common side effects of chemotherapy, and can cause persistent negative emotions, further affecting therapeutic effects and reducing the quality of life. However, there are no clini...
Source: Trials - Category: General Medicine Authors: Tags: Study protocol Source Type: research
"Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia". Breast. 2019 Dec 12;49:187-193 Authors: Bajpai J, Kagwade S, Chandrasekharan A, Dandekar S, Kanan S, Kembhavi Y, Ghosh J, Banavali SD, Gupta S Abstract BACKGROUND: Randomized controlled trials (RCT) of scalp cooling (SC) to prevent chemotherapy induced alopecia (CIA) did not evaluate its effect on hair regrowth (HR) and was conducted in a predominantly taxane (T) treated population. We conducted an RCT of SC in a setting of anthracycline (A) and taxane chemotherapy (CT) and assessed its effect...
Source: Breast - Category: Cancer & Oncology Authors: Tags: Breast Source Type: research
DiscussionThis research is of great significance for the treatment of cancer and improving the quality of life of cancer patients. The study may provide the most direct evidence for meeting clinical needs and lay a solid scientific foundation for later product development.Trial registrationChinese Clinical Trial Registry, ID:ChiCTR1800020107. Registered on 14 December 2018.
Source: Trials - Category: Research Source Type: clinical trials
s TRP Abstract OBJECTIVE: To comprehensively analyze the perception of women with breast cancer on the experience of undergoing chemotherapy. METHOD: This was a qualitative, descriptive, phenomenological study, supported by the Merleau-Ponty philosophy. It was conducted in a chemotherapy outpatient clinic with 20 participants who completed a phenomenological interview. RESULTS: The phenomenological data analysis demonstrated that the perception of women about the experience of chemotherapy is about change, not only of the physical body, but of their identity, and that it considers existential aspects. Th...
Source: Revista Brasileira de Enfermagem - Category: Nursing Authors: Tags: Rev Bras Enferm Source Type: research
Conditions:   Breast Cancer;   Breast Cancer Stage I;   Breast Cancer Stage II;   Breast Cancer Stage III Intervention:   Device: PAXMAN Scalp Cooler Sponsor:   Memorial Sloan Kettering Cancer Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alopecia | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Middle East Health | Study | Toxicology | Turkey Health